Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €73.00 by Sanford C. Bernstein

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €73.00 ($84.88) target price by Sanford C. Bernstein in a note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock. Sanford C. Bernstein’s target price indicates a potential upside of 11.48% from the stock’s current price.

FME has been the topic of a number of other reports. Goldman Sachs Group set a €80.00 ($93.02) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Berenberg Bank set a €89.95 ($104.59) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Tuesday, October 29th. Jefferies Financial Group set a €69.00 ($80.23) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Tuesday, October 29th. Nord/LB set a €82.00 ($95.35) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Finally, Kepler Capital Markets set a €70.00 ($81.40) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Tuesday, October 29th. Eight investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of €77.57 ($90.19).

Shares of FME stock traded down €0.34 ($0.40) on Tuesday, reaching €65.48 ($76.14). The stock had a trading volume of 652,767 shares, compared to its average volume of 704,197. The stock has a market cap of $19.97 billion and a P/E ratio of 15.58. Fresenius Medical Care AG & Co. KGaA has a 1 year low of €55.44 ($64.47) and a 1 year high of €76.68 ($89.16). The company has a debt-to-equity ratio of 101.27, a quick ratio of 0.62 and a current ratio of 0.98. The company has a 50 day simple moving average of €62.12 and a 200 day simple moving average of €65.49.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: Do back-end load funds outperform no-load funds?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.